Zobrazeno 1 - 10
of 25
pro vyhledávání: '"Giada Acciaroli"'
Publikováno v:
Sensors, Vol 19, Iss 17, p 3677 (2019)
Even if still at an early stage of development, non-invasive continuous glucose monitoring (NI-CGM) sensors represent a promising technology for optimizing diabetes therapy. Recent studies showed that the Multisensor provides useful information about
Externí odkaz:
https://doaj.org/article/b77c57ebeed743f6af96af6d791a8475
Publikováno v:
Biosensors, Vol 8, Iss 1, p 24 (2018)
Minimally invasive continuous glucose monitoring (CGM) sensors are wearable medical devices that provide real-time measurement of subcutaneous glucose concentration. This can be of great help in the daily management of diabetes. Most of the commercia
Externí odkaz:
https://doaj.org/article/9931ec57df1f48e1afbe46eda1d075b4
Autor:
Giada Acciaroli, Christopher G. Parkin, Roy Thomas, Jennifer Layne, Gregory J. Norman, Keri Leone
Publikováno v:
Diabetic Medicine. 40
Publikováno v:
Journal of diabetes science and technology.
Publikováno v:
Diabetic Medicine. 40
Regional variations in the adoption of diabetes technology may be reflected in population-level metrics of glycaemic control. In this observational study, we aimed to assess the glycaemic impacts of transitioning from the Dexcom G5 Real-Time Continuo
Publikováno v:
J Diabetes Sci Technol
Background: Excess carbohydrate intake during hypoglycemia can lead to rebound hyperglycemia (RH). We investigated associations between RH and use of real-time continuous glucose monitoring (rtCGM) and an rtCGM system’s predictive alert. Methods: R
Autor:
Tomas C. Walker, Sarah Puhr, John B. Welsh, Halis Kaan Akturk, Giada Acciaroli, Andrew Scott Parker
Publikováno v:
Diabetes. 69
Symptomatic hypoglycemia is an incentive for carbohydrate intake which, in excess, can lead to rebound hyperglycemia (RH) and contribute to high glycemic variability. We examined whether an optional "urgent low soon" (ULS) alert triggered by impendin
Autor:
Giada Acciaroli, John B. Welsh, Tomas C. Walker, Andrew Scott Parker, Keri J. Leone, David Price
Publikováno v:
Diabetes. 69
The coefficient of variation (CV) of CGM-derived sensor glucose values (SGVs) is the preferred metric for glycemic variability. However, a high CV is not directly actionable. We hypothesized that overtreatment of hyperglycemia (leading to iatrogenic
Autor:
Giada Acciaroli, David Ahn, Tadej Battelino, Rachel Brandt, Marc D. Breton, Enrique Campos-Náñez, Ali Cinar, William L. Clarke, Claudio Cobelli, Andrew DeHennis, Simone Del Favero, Laya Ekhlaspour, Chiara Fabris, Andrea Facchinetti, Gregory P. Forlenza, Kurt Fortwaengler, Satish Garg, Iman Hajizadeh, Nicole Hobbs, David Klonoff, Boris Kovatchev, Mark Mortellaro, Laura M. Nally, Nick Oliver, Mudassir Rashid, Monika Reddy, Amanda Rewers, Sediqeh Samadi, Mert Sevil, Viral N. Shah, Jennifer L. Sherr, Darja Smigoc Schweiger, Giovanni Sparacino, Chukwuma Uduku, Martina Vettoretti
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::96f3c93d8a720475048e1d65dd43a9a1
https://doi.org/10.1016/b978-0-12-816714-4.01002-4
https://doi.org/10.1016/b978-0-12-816714-4.01002-4
Most of the commercially available continuous glucose monitoring devices have a wired-based sensor, usually placed in the subcutaneous tissue, which measures a “raw” current signal via a glucose-oxidase electrochemical reaction. This electrical s
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::63aaa9e40133d3782aee9061d5bf8ef5
https://doi.org/10.1016/b978-0-12-816714-4.00009-0
https://doi.org/10.1016/b978-0-12-816714-4.00009-0